Related references
Note: Only part of the references are listed.Novel search method for the discovery of functional relationships
Fidel Ramirez et al.
BIOINFORMATICS (2012)
Colon cancer molecular subtypes identified by expression profiling and associated to stroma, mucinous type and different clinical behavior
Beatriz Perez-Villamil et al.
BMC CANCER (2012)
Prognostic gene expression signature associated with two molecularly distinct subtypes of colorectal cancer
Sang Cheul Oh et al.
GUT (2012)
Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR
Anirudh Prahallad et al.
NATURE (2012)
Systematic identification of genomic markers of drug sensitivity in cancer cells
Mathew J. Garnett et al.
NATURE (2012)
Recurrent R-spondin fusions in colon cancer
Somasekar Seshagiri et al.
NATURE (2012)
Comprehensive molecular characterization of human colon and rectal cancer
Donna M. Muzny et al.
NATURE (2012)
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
Jordi Barretina et al.
NATURE (2012)
KEGG for integration and interpretation of large-scale molecular data sets
Minoru Kanehisa et al.
NUCLEIC ACIDS RESEARCH (2012)
Molecular Genetics of Colorectal Cancer
Eric R. Fearon
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 6 (2011)
EMT is the dominant program in human colon cancer
Andre Loboda et al.
BMC MEDICAL GENOMICS (2011)
Global Cancer Statistics
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2011)
Methylation of Cancer-Stem-Cell-Associated Wnt Target Genes Predicts Poor Prognosis in Colorectal Cancer Patients
Felipe de Sousa e Melo et al.
CELL STEM CELL (2011)
Increased Detection Sensitivity for KRAS Mutations Enhances the Prediction of Anti-EGFR Monoclonal Antibody Resistance in Metastatic Colorectal Cancer
Francesca Molinari et al.
CLINICAL CANCER RESEARCH (2011)
Colorectal Cancer Epigenetics: Complex Simplicity
Manon van Engeland et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Gene Expression Signature to Improve Prognosis Prediction of Stage II and III Colorectal Cancer
Ramon Salazar et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Cetuximab Plus Irinotecan, Fluorouracil, and Leucovorin As First-Line Treatment for Metastatic Colorectal Cancer: Updated Analysis of Overall Survival According to Tumor KRAS and BRAF Mutation Status
Eric Van Cutsem et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Insertional mutagenesis identifies multiple networks of cooperating genes driving intestinal tumorigenesis
H. Nikki March et al.
NATURE GENETICS (2011)
Microsatellite instability in colorectal cancer
Barry Iacopetta et al.
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY (2010)
A flexible R package for nonnegative matrix factorization
Renaud Gaujoux et al.
BMC BIOINFORMATICS (2010)
Molecular Target Class Is Predictive of In vitro Response Profile
Joel Greshock et al.
CANCER RESEARCH (2010)
Transcriptional Pathway Signatures Predict MEK Addiction and Response to Selumetinib (AZD6244)
Jonathan R. Dry et al.
CANCER RESEARCH (2010)
Targeted Therapies as Adjuvant Treatment for Early-Stage Colorectal Cancer: First Impressions and Clinical Questions
Benoist Chibaudel et al.
CLINICAL COLORECTAL CANCER (2010)
Colorectal Cancer Cell Lines Lack the Molecular Heterogeneity of Clinical Colorectal Tumors
James Todd Auman et al.
CLINICAL COLORECTAL CANCER (2010)
Experimentally Derived Metastasis Gene Expression Profile Predicts Recurrence and Death in Patients With Colon Cancer
J. Joshua Smith et al.
GASTROENTEROLOGY (2010)
Relationship Between Tumor Gene Expression and Recurrence in Four Independent Studies of Patients With Stage II/III Colon Cancer Treated With Surgery Alone or Surgery Plus Adjuvant Fluorouracil Plus Leucovorin
Michael J. O'Connell et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Discovering causal signaling pathways through gene-expression patterns
Jignesh R. Parikh et al.
NUCLEIC ACIDS RESEARCH (2010)
Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes
Joseph H. Taube et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Genetic and epigenetic classifications define clinical phenotypes and determine patient outcomes in colorectal cancer
J. A. Sanchez et al.
BRITISH JOURNAL OF SURGERY (2009)
Metastasis-Associated Gene Expression Changes Predict Poor Outcomes in Patients with Dukes Stage B and C Colorectal Cancer
Robert N. Jorissen et al.
CLINICAL CANCER RESEARCH (2009)
Molecular Origins of Cancer: Molecular Basis of Colorectal Cancer.
Sanford D. Markowitz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
PID: the Pathway Interaction Database
Carl F. Schaefer et al.
NUCLEIC ACIDS RESEARCH (2009)
A Transposon-Based Genetic Screen in Mice Identifies Genes Altered in Colorectal Cancer
Timothy K. Starr et al.
SCIENCE (2009)
Colon Cancer: It's CIN or CIMP
Jean-Pierre Issa
CLINICAL CANCER RESEARCH (2008)
Gender differences in colorectal cancer incidence, mortality, hospitalizations and surgical procedures in Canada
Ru-Nie Gao et al.
JOURNAL OF PUBLIC HEALTH (2008)
被撤回的出版物: A genomic approach to colon cancer risk stratification yields biologic insights into therapeutic opportunities (Retracted Article. See vol 106, pg 6878, 2009)
Katherine S. Garman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Death-receptor O-glycosylation controls tumor-cell sensitivity to the proapoptotic ligand Apo2L/TRAIL
Klaus W. Wagner et al.
NATURE MEDICINE (2007)
Multiple gene expression classifiers from different array platforms predict poor prognosis of colorectal cancer
Yu-Hsin Lin et al.
CLINICAL CANCER RESEARCH (2007)
Gene expression profiles of primary colorectal carcinomas, liver metastases, and carcinomatoses
Kristine Kleivi et al.
MOLECULAR CANCER (2007)
Stage II colon cancer prognosis prediction by tumor gene expression profiling
Alain Barrier et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Clusterin inhibits apoptosis by interacting with activated Bax
HL Zhang et al.
NATURE CELL BIOLOGY (2005)
Gene-expression profiling predicts recurrence in Dukes' C colorectal cancer
D Arango et al.
GASTROENTEROLOGY (2005)
Synchronous global assessment of gene and protein expression in colorectal cancer progression
KY Kwong et al.
GENOMICS (2005)
Molecular staging for survival prediction of colorectal cancer patients
S Eschrich et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Gene expression profiling of colon cancer by DNA microarrays and correlation with histoclinical parameters
F Bertucci et al.
ONCOGENE (2004)
affy -: analysis of Affymetrix GeneChip data at the probe level
L Gautier et al.
BIOINFORMATICS (2004)
Gene expression profiles and molecular markers to predict recurrence of dukes' B colon cancer
YX Wang et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Bioconductor: open software development for computational biology and bioinformatics
RC Gentleman et al.
GENOME BIOLOGY (2004)
DACH1 inhibits transforming growth factor-β signaling through binding Smad4
KM Wu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Essential requirement of apolipoprotein J (clusterin) signaling for IκB expression and regulation of NF-κB activity
G Santilli et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Share Paper
